Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1751223

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1751223

Activated Carbon For Pharma & Healthcare Market Size, Share & Trends Analysis Report By Form (Powdered, Granular), By Application (API Production, Finished Drug Production), By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 132 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Activated Carbon For Pharma & Healthcare Market Growth & Trends:

The global activated carbon for pharma & healthcare market size is anticipated to reach USD 652.1 million by 2030 and is expected to grow at a CAGR of 6.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for activated carbon in the pharmaceutical and healthcare sectors continues to grow, largely due to its exceptional ability to purify and adsorb contaminants. In hospitals, it plays a vital role in maintaining clean air and water, while in pharmaceutical manufacturing, it's used to remove impurities and unwanted colorants from medications. Medical-grade activated carbon, approved for human use, is also a critical tool in emergency medicine for treating poisonings. It works by binding to toxins in the gastrointestinal tract, stopping them from being absorbed into the body, a life-saving measure in cases of overdose or accidental ingestion.

This rising demand is also tied to the significant challenge posed by hospital-acquired infections (HAIs) in the U.S. Each year, approximately 1.7 million patients, roughly 5% to 10% of those hospitalized, develop an HAI, with close to 100,000 resulting deaths. These numbers highlight a serious public health concern that exceeds the impact of many other major diseases. To combat this, healthcare facilities are turning to advanced purification technologies, with activated carbon being a top choice due to its efficiency in filtering harmful particles and pathogens.

In addition, activated carbon is heavily utilized in the pharmaceutical industry for its high porosity and excellent adsorption capabilities, which are enhanced through thermal processing. These properties allow it to effectively remove contaminants, pigments, and residues during drug production, improving the final product's quality and safety.

Activated Carbon For Pharma & Healthcare Market Highlights

  • Based on form, the powdered form dominated the market with the largest revenue share of 56.3% in 2024.
  • The granular activated carbon market for the pharmaceutical and healthcare industry is estimated to grow at the fastest CAGR over the forecast period.
  • Its superior absorption, easy handling, storage, and ability to withstand repeated filtration cycles drive the growth.
  • Based on application, API production led the activated carbon market for the pharma & healthcare industry, accounting for the largest revenue share in 2024.
  • The finished drug production segment is expected to grow at a significant CAGR of 6.2% over the forecast period.
  • Asia Pacific dominated the global market with the largest revenue share of 48.6% in 2024.
  • The rise in pharmaceutical production across Asian countries fueled the demand for more efficient purification methods during production.
Product Code: GVR-4-68040-564-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Activated Carbon For Pharma & Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macro-environmental Analysis

Chapter 4. Activated Carbon For Pharma & Healthcare Market: Form Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Activated Carbon For Pharma & Healthcare Market: Form Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Powdered
    • 4.3.1. Powdered Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.4. Granular
    • 4.4.1. Granular Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.5. Other Form
    • 4.5.1. Other Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)

Chapter 5. Activated Carbon For Pharma & Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Activated Carbon For Pharma & Healthcare Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. API Production
    • 5.3.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in API Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.4. Finished Drug Production
    • 5.4.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.5. Others
    • 5.5.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Other Applications, 2018 - 2030 (Kilotons, USD Million)

Chapter 6. Activated Carbon For Pharma & Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Movement Analysis & Market Share, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key country dynamics
      • 6.2.2.2. U.S. activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key country dynamics
      • 6.2.3.2. Canada activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key country dynamics
      • 6.2.4.2. Mexico activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.3. Europe
    • 6.3.1. Europe activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Germany activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. UK activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. France activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key country dynamics
      • 6.3.5.2. Italy activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key country dynamics
      • 6.3.6.2. Spain activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.2. China
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. China activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.3. India
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. India activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Japan activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. South Korea activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Australia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Brazil activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Argentina activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. South Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Saudi Arabia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)

Chapter 7. Activated Carbon For Pharma & Healthcare Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Form Launches
    • 7.5.5. Research And Development
  • 7.6. Company Profiles
    • 7.6.1. Jacobi Group
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Form benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Chemviron (a Kuraray Company)
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Form benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Haycarb PLC
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Form benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Boyce Carbon
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Form benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. Southern Carbon Pvt. Ltd.
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Form benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. Suneeta Carbons
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Form benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Calgon Carbon Corporation
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Form benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Karbonous Inc.
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Form benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Norit
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Form benchmarking
      • 7.6.9.4. Recent developments
    • 7.6.10. Donau Carbon GmbH
      • 7.6.10.1. Participant's overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Form benchmarking
      • 7.6.10.4. Recent developments
Product Code: GVR-4-68040-564-7

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Activated carbon for pharma & healthcare market 2018 - 2030 (Kilotons) (USD Million)
  • Table 3. Global activated carbon for pharma & healthcare market estimates and forecasts by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 4. Global activated carbon for pharma & healthcare market estimates and forecasts by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 5. Global activated carbon for pharma & healthcare market estimates and forecasts by region, 2018 - 2030 (Kilotons) (USD Million)
  • Table 6. North America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 7. North America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 8. North America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 9. U.S. activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 10. U.S. activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 11. Canada activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 12. Canada activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 13. Mexico activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 14. Mexico activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 15. Europe activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 16. Europe activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 17. Europe activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 18. Germany activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 19. Germany activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 20. UK activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 21. UK activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 22. France activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 23. France activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 24. Italy activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 25. Italy activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 26. Spain activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 27. Spain activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 28. Asia Pacific activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 29. Asia Pacific activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 30. Asia Pacific activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 31. China activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 32. China activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 33. India activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 34. India activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 35. Japan activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 36. Japan activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 37. South Korea activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 38. South Korea activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 39. Australia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 40. Australia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 41. Latin America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 42. Latin America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 43. Latin America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 44. Brazil activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 45. Brazil activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 46. Argentina activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 47. Argentina activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 48. Middle East & Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 49. Middle East & Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 50. Middle East & Africa activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 51. South Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 52. South Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 53. Saudi Arabia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 54. Saudi Arabia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 Activated Carbon For Pharma & Healthcare Market Snapshot
  • Fig. 11 Form Segment Snapshot (1/2)
  • Fig. 12 Application Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 Activated Carbon For Pharma & Healthcare Market Value, 2024 (Kilotons) (USD Million)
  • Fig. 16 Activated Carbon For Pharma & Healthcare Market - Value Chain Analysis
  • Fig. 17 Activated Carbon For Pharma & Healthcare Market - Market Dynamics
  • Fig. 18 Activated Carbon For Pharma & Healthcare Market - PORTER's Analysis
  • Fig. 19 Activated Carbon For Pharma & Healthcare Market - PESTEL Analysis
  • Fig. 20 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Form: Key Takeaways
  • Fig. 21 Activated Carbon For Pharma & Healthcare Market Share, By Form, 2024 & 2030
  • Fig. 22 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Powdered Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 23 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Granular Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 24 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Application: Key Takeaways
  • Fig. 25 Activated Carbon For Pharma & Healthcare Market Share, By Application, 2024 & 2030
  • Fig. 26 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in API Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 27 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 28 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Others, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 29 Activated Carbon For Pharma & Healthcare Market Revenue, By Region, 2024 & 2030 (Kilotons) (USD Million)
  • Fig. 30 North America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 31 U.S. Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 32 Canada Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 33 Mexico Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 34 Europe Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 35 Germany Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 36 UK Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 37 France Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 38 Italy Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 39 Spain Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 40 Asia Pacific Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 41 China Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 42 India Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 43 Japan Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 44 South Korea Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 45 Australia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 46 Latin America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 47 Brazil Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 48 Argentina Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 49 Middle East & Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 50 South Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 51 Saudi Arabia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 52 Key Company Categorization
  • Fig. 53 Company Market Positioning
  • Fig. 54 Strategy Mapping
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!